top of page

Search Results

383 results found with an empty search

  • Pitfalls to Avoid When Marketing Products | Asa Waldstein

    < Back Webinar Thursday Mar 7, 2024 Pitfalls to Avoid When Marketing Products Velocity CPG Guest speaker Asa Waldstein reviews common pitfalls when marketing products that can lead to expensive litigation or agency action such as social media engagement, citing clinical studies, blogs, and influencer best practices. Register Previous Next

  • Ethical Product Marketing in the Coronavirus Era: Town Hall | Asa Waldstein

    < Back Webinar Thursday Apr 23, 2020 Ethical Product Marketing in the Coronavirus Era: Town Hall Asa's Regulatory Education Series Discussing the do's and don'ts of marketing products during the Coronavirus era. I will be joined by two special guests which cover the expert legal, regulatory, and marketing sides of the industry. Linda Nielander is VP of Sales and Marketing for Quicksilver Scientific. Erica W. Stump is the owner and founder the Erica W. Stump, P.A. law firm. Watch Previous Next

  • Q4 2024 warning letter roundup with Asa Waldstein

    In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. < Back Q4 2024 warning letter roundup with Asa Waldstein Asa Waldstein Guest Article In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. Each quarter, Asa provides updates on notable FDA warning letters and enforcement trends. Understanding enforcement trends is essential for being a savvy marketer, regulatory affairs professional or dietary supplement executive. Have you wondered why FDA issues warning letters to certain companies and not others? FDA likes to make examples of companies not following the rules in areas they want to focus on, many of which Asa reviews here. Staying ahead of trouble is one of the critical and fun reasons to follow enforcement trends. 2024 has been noticeably light in dietary supplement warning letters, and I don’t have a good guess as to why. Dozens of companies continue to make extreme disease claims — such as the treatment, prevention or mitigation of cancer — about their products or ingredients. I expect more regulatory action in the months to come. Read More for Asa's 2025 Predictions. Read More Previous Next

  • Distributor Pitfalls to Avoid | Asa Waldstein

    < Back Webinar Thursday Jun 3, 2021 Distributor Pitfalls to Avoid Asa's Regulatory Education Series Nathalie Bougenies and Steven Yeager join me for our next Regulatory Education Series event. What companies need to consider when distributing products? Here are some of the topics we will cover. What contracts do distributors need to have in place? What CFR 111 requirements do distributors need to comply with? What Prop 65 liabilities do distributors carry? What is the liability of the distributor? What liabilities do platforms which sell lots of products and making claims have? How do distributors handle product returns? Do they need to be tested before going back into inventory? And more! Learn More Previous Next

  • New year, same problem: FDA issues tejocote root warning, finding the supplements adulterated with poisonous plant

    The supplements labeled as weight loss products appear to be mislabeled as testing revealed the tejocote root was substituted with a potentially deadly plant. < Back New year, same problem: FDA issues tejocote root warning, finding the supplements adulterated with poisonous plant Danielle Masterson Interview The supplements labeled as weight loss products appear to be mislabeled as testing revealed the tejocote root was substituted with a potentially deadly plant. Read More Previous Next

  • Product Reviews & Marketing Claims

    Asa and other industry leaders interviewed < Back Product Reviews & Marketing Claims Kate Robertson Interview Asa and other industry leaders interviewed Read More Previous Next

  • Stress: What can you claim on a product label?

    Asa Waldstein and two top advertising attorneys share their tips and best practices for marketing stress supplements. 🔷Stress-free rules Ivan Wasserman, Amin Talati Wasserman, LLP 🔷Pooja's do's and don'ts Pooja Nair 🔷Asa's helpful hints Supplement Advisory Group < Back Stress: What can you claim on a product label? Danielle Masterson Interview Asa Waldstein and two top advertising attorneys share their tips and best practices for marketing stress supplements. 🔷Stress-free rules Ivan Wasserman, Amin Talati Wasserman, LLP 🔷Pooja's do's and don'ts Pooja Nair 🔷Asa's helpful hints Supplement Advisory Group Read More Previous Next

  • Compliance responsibilities when using a contract manufacturer

    Brands need to ensure regulatory responsibilities are accounted for at the start of a contract manufacturing partnership. < Back Compliance responsibilities when using a contract manufacturer Rachel Adams Press Mention Brands need to ensure regulatory responsibilities are accounted for at the start of a contract manufacturing partnership. Read More Previous Next

  • Sales soar for probiotic-containing soft drinks

    Reporting of a SupplySide West presentation < Back Sales soar for probiotic-containing soft drinks Jeff Gelski Interview Reporting of a SupplySide West presentation Read More Previous Next

  • Decoding the Regulations Around Cannabinoid Enforcement & Marketing Claims | Asa Waldstein

    < Back Presentation Tuesday Nov 15, 2022 Decoding the Regulations Around Cannabinoid Enforcement & Marketing Claims MJBizCon, Las Vegas, NV The FDA has not been shy about sending enforcement letters even with a lack of regulation and guidance. Operators in the hemp-CBD/cannabinoid marketplace can limit their risk, while still being truthful and not misleading. But what exactly is that magical line businesses cannot cross before getting a Dear John from the FDA? This session will identify high-risk marketing strategies and how to adapt accordingly. You will learn: - Recent enforcement trends across the industry - How to identify high-risk verbiage and example of lower-risk verbiage to communicate the same message - What is top of mind and what the FDA is looking for when reviewing claims in testimonials, hashtags influences and Tik Tok. - How to read enforcement actions (i.e. warning letters) and your next steps - Q&A at the end Session Date: Tuesday, November 15th, 2022 See the agenda here . Learn More Previous Next

  • Effective and practical marketing compliance | Asa Waldstein

    < Back Interview Thursday Jul 15, 2021 Effective and practical marketing compliance Insider in the Afternoon We speak about structure-function claims, disease claims, marketing risk versus reward, and clever product names. Watch Previous Next

  • Vitafoods Europe Startup Innovation Challenge 2024 | Asa Waldstein

    < Back In-Person, Presentation Tuesday May 14, 2024 Vitafoods Europe Startup Innovation Challenge 2024 Vitafoods Europe Geneva, Switzerland Apex Compliance has been invited as a start up finalist. Asa Waldstein will be on stage as a "top 6" finalist in the most innovative digital solution for the nutraceutical industry. Apex Compliance and five other companies have been selected in this category. Most Innovative Service, Technology, or Digital Solution Supporting the Nutraceutical Industry This is a "shark tank" style pitch where Asa will present our technology to an expert panel behind closed doors and also present on stage to the Vitafoods Europe audience. See Asa's LinkedIn post about this event here . Learn more Previous Next

AHPA-member-logo.png
  • LinkedIn
  • YouTube
  • Facebook

American Herbal Products Association (AHPA) Member

©2024 by Supplement Advisory Group LLC. All Rights Reserved

Disclaimer: The educational information provided on this website is for informational purposes only. Contact an attorney for specific legal advice.  Rule #1 in compliance is to ensure marketing is truthful and not misleading.

Privacy Policy. |. Terms of Use. |. Sitemap

bottom of page